FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/11/022184 [Registered on: 27/11/2019] Trial Registered Prospectively
Last Modified On: 25/11/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Role of drugs fentanyl and dexmedetomidine for the treatment of headache after spinal anaesthesia 
Scientific Title of Study   Efficacy of Fentanyl and Dexmedetomidine nebulization for obstetric PDPH: A Randomised controlled pilot study. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Amarjeet Kumar 
Designation  Assistant Professor 
Affiliation  AIIMS Patna 
Address  Department of anaesthesia,Room no-503,5th floor ,B -Block AIIMS Patna

Patna
BIHAR
801507
India 
Phone  9570890646  
Fax    
Email  amarjeetdmch@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amarjeet Kumar 
Designation  Assistant Professor 
Affiliation  AIIMS Patna 
Address  Department of anaesthesia,Room no-503,5th floor ,B -Block AIIMS Patna

Patna
BIHAR
801507
India 
Phone  9570890646  
Fax    
Email  amarjeetdmch@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amarjeet Kumar 
Designation  Assistant Professor 
Affiliation  AIIMS Patna 
Address  Department of anaesthesia,Room no-503,5th floor ,B -Block AIIMS Patna

Patna
BIHAR
801507
India 
Phone  9570890646  
Fax    
Email  amarjeetdmch@gmail.com  
 
Source of Monetary or Material Support  
AIIMS, Patna 
 
Primary Sponsor  
Name  AIIMS Patna 
Address  Department of Obstetric and gynaecology, B-Block, AIIMS, Patna 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
AIIMS Patna  Department of Obstetric and gynaecology, B-Block, AIIMS, Patna 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amarjeet Kumar  AIIMS, Patna  Department of Obstetric and gynaecology,Gynae ward, B-Block
Patna
BIHAR 
9570890646

amarjeetdmch@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC AIIMS, Patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R298||Other symptoms and signs involvingthe nervous and musculoskeletal systems,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nebulization with dexmedetomidine 1µg/kg after PDPH  Patient will be nebulized with dexmedetomidine dose 1µg/kg diluted with normal saline to total volume 4ml by using ultrasonic nebulizer 12 hrly for 3days. 
Comparator Agent  Nebulized with 4ml normal saline after PDPH  Patient will be nebulized with volume 4ml normal saline using ultrasonic nebulizer 12 hrly for 3 days. 
Intervention  Nebulized with fentanyl 1µg/kg after PDPH   Patient will be nebulized with fentanyl dose 1µg/kg diluted diluted with normal saline to total volume 4ml by using ultrasonic nebulizer 12 hrly for 3 days. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  . ASA I/II
.Complain of post spinal headache within 5 days following cesarean section 
 
ExclusionCriteria 
Details  1. Unconscious and uncooperative patients
2. Allergic to dexmedetomidine/fentanyl
3 Asthmatics.
4. Epileptics
5. patient having history of migraine,other types headache
6.On chronic treatment of headache
7.Haemodynamic instability,bradyarrthymias
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Decrease in Headache severity will be monitored using Numerical rating scale(NRS)   Base line, during procedure, after procedure, hourly for the first 24 hours, followed by 2nd hourly next 24 hours and thereafter 
 
Secondary Outcome  
Outcome  TimePoints 
Total analgesic consumption   Within 3days after development of PDPH 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/12/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Post dural puncture headache (PDPH) after spinal anaesthesia is excruciating in nature and some times associated with neck stiffness, tinnitus, photophobia and vomitining. Several drugs are used to control post dural puncture headache like paracetamol, caffeine, sumatriptan, dexmedetomidine, and others non-steroidal antiinflmatory drug.This study is designed to compare the analgesic effect of two different drug dexmedetomidine and fentanyl through inhalational route 
Close